Skip to main content

Table 2 Prevalent pre-admission RASP PIMs, other than potentially inadequate inhalation in COPD

From: Medication review versus usual care to improve drug therapies in older inpatients not admitted to geriatric wards: a quasi-experimental study (RASP-IGCT)

RASP item

Usual Care (n = 29)

Intervention (n = 30)

p value

Prolonged use of PPI or H2RA in peptic ulcer disease

11

8

0.412

Prolonged use of benzodiazepines, zolpidem, zopiclone or zaleplon

7

11

0.399

Prolonged use of antidepressants

5

10

0.233

Sedatives and hypnotics: benzodiazepines/zaleplon/zolpidem/zopiclone in fallers

9

6

0.382

Inadequate use of inhalation therapy in patients with moderate/severe cognitive and/or functional disability

6

8

0.761

Antidepressants in fallers

8

5

0.360

Vitamins, minerals and trace elements without documented deficiency

7

6

0.761

Additional dietary supplements without any documented need, not described in other RASP criteria (e.g. glucosamine)

2

6

0.254

Venotropic drugs

3

4

1.000

Antihypertensive drugs in the presence of postural hypotension

5

1

0.103

  1. COPD chronic obstructive pulmonary disease
  2. RASP Rationalization of Home Medication by an Adjusted STOPP in Older Patients
  3. PIM potentially inappropriate medication
  4. PPI proton pump inhibitor
  5. H2RA histamine-2 receptor antagonist